Published in Am J Gastroenterol on November 01, 1986
An apricot story: view through a keyhole. World J Emerg Surg (2007) 0.84
Food entrapped in papilla of Vater: uncommon cause of vomiting. Arch Dis Child (2000) 0.75
EXPERIMENTAL PNEUMONIA BY INTRABRONCHIAL INSUFFLATION. J Exp Med (1912) 31.80
EXPERIMENTAL BRONCHOPNEUMONIA BY INTRABRONCHIAL INSUFFLATION. J Exp Med (1912) 8.95
PNEUMONIC LESIONS MADE BY INTRABRONCHIAL INSUFFLATION OF NON-VIRULENT PNEUMOCOCCI. J Exp Med (1913) 5.14
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res (2000) 2.99
EXPERIMENTAL CONTRIBUTION TO THE STUDY OF THE PATH BY WHICH FLUIDS ARE CARRIED FROM THE PERITONEAL CAVITY INTO THE CIRULATION. J Exp Med (1896) 2.94
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med (1989) 2.70
THE REACTION OF THE LUNGS TO THE INTRABRONCHIAL INSUFFLATION OF KILLED VIRULENT PNEUMOCOCCI AND OF PLAIN STERILE BOUILLON. J Exp Med (1913) 2.53
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology (1994) 2.20
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
PNEUMONIC LESIONS CAUSED BY BACILLUS MEGATHERIUM. J Exp Med (1913) 2.10
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (2000) 2.05
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol (1999) 1.98
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res (1998) 1.94
On the Respiratory Changes of the Intrathoracic Pressure, measured in the Mediastinum Posterior. J Physiol (1892) 1.89
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene (2000) 1.63
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene (2006) 1.55
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene (2002) 1.54
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res (2001) 1.52
Prevalence of glycosuria and diabetes among Indians and Bantu. S Afr Med J (1969) 1.50
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
Retention in the Circulation of Dextrose in Normal and Depancreatized Animals, and the Effect of an Intravenous Injection of an Emulsion of Pancreas Upon This Retention. Proc Natl Acad Sci U S A (1915) 1.45
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology (1997) 1.42
THE RELATION OF THE RATE OF ABSORPTION OF ADRENALIN TO ITS GLYCOSURIC AND DIURETIC EFFECTS. J Exp Med (1913) 1.40
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res (2001) 1.39
Growth suppression of esophageal cancer cells by p16INK4 and p15INK4B in vitro. Cancer J Sci Am (2006) 1.39
AN EXPERIMENTAL STUDY OF THE ADDITIVE AND ANTAGONISTIC ACTIONS OF SODIUM OXALATE, AND SALTS OF MAGNESIUM AND CALCIUM IN THE RABBIT. J Exp Med (1916) 1.38
The Dynamics of Living Matter. Science (1906) 1.37
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology (1993) 1.36
Appendiceal obstruction by a toothpick removed at colonoscopy. Am J Gastroenterol (1986) 1.33
Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology (1996) 1.33
Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res (1995) 1.31
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene (2007) 1.31
EXPERIMENTAL CHEMICAL PNEUMONIA. J Exp Med (1918) 1.31
Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol (2001) 1.30
ABC of colorectal cancer. Molecular basis for risk factors. BMJ (2000) 1.30
MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene (2010) 1.25
Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene (1994) 1.21
Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res (1994) 1.20
Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res (1992) 1.18
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer (1998) 1.18
Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene (2001) 1.17
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene (2001) 1.17
APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology (1994) 1.14
Prenatal diagnosis and the pediatric surgeon: the impact of prenatal consultation on perinatal management. J Pediatr Surg (1996) 1.11
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res (2001) 1.11
Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res (2000) 1.10
Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res (1997) 1.09
The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res (1997) 1.09
Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene (1999) 1.08
Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol (1999) 1.07
Protooncogene abnormalities in colon cancers and adenomatous polyps. Gastroenterology (1987) 1.07
Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res (1992) 1.07
Following in mother's footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes. Diabet Med (2010) 1.05
Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Cancer Res (1993) 1.05
Triplet and quadruplet pregnancies and management. Obstet Gynecol (1981) 1.05
Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer (1995) 1.04
Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene (1996) 1.03
p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol (1994) 0.99
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res (1991) 0.99
Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers. Oncogene (1998) 0.97
Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. Lab Invest (1996) 0.97
The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene (1994) 0.96
EFFECT OF INTRABRONCHIAL INSUFFLATION OF SOLUTIONS OF SOME INORGANIC SALTS. J Exp Med (1918) 0.95
THE DEPLORABLE CONTRAST BETWEEN INTRANATIONAL AND INTERNATIONAL ETHICS AND THE MISSION OF MEDICAL SCIENCE AND MEDICAL MEN. Science (1915) 0.94
Giant pseudopolyposis in colitis with colonic intussusception. Gastroenterology (1978) 0.94
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract. Oncogene (1999) 0.94
The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res (1991) 0.92
Kaposi's sarcoma occurring in association with ulcerative colitis. Am J Gastroenterol (1987) 0.92
FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Oncogene (1997) 0.91
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology (1986) 0.91
Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology (1994) 0.90
Effectiveness, reproducibility, and weight-relation of screening-tests for diabetes. Lancet (1968) 0.90
Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res (1994) 0.90
Esophagin cDNA cloning and characterization: a tissue-specific member of the small proline-rich protein family that is not expressed in esophageal tumors. Cell Growth Differ (1996) 0.89
THE CHARACTER OF THE PNEUMONIC LESIONS PRODUCED BY INTRABRONCHIAL INSUFFLATION OF VIRULENT STREPTOCOCCI. J Exp Med (1913) 0.89
The molecular basis for carcinogenesis in metaplastic columnar-lined esophagus. Gastroenterol Clin North Am (1997) 0.89
Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res (1997) 0.89
Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. Cancer Res (1998) 0.88
Explant organ culture: a review. Cytotechnology (1991) 0.88
Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum Mutat (1997) 0.87
Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer (1993) 0.87
Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene (1999) 0.87
The outcome of pregnancy after gonadotrophin therapy. Br J Obstet Gynaecol (1976) 0.87
Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology (1998) 0.86
Sugar intake and diabetes. Diabetes (1967) 0.86
Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines. Genes Chromosomes Cancer (1995) 0.85
On the Paths of Absorption from the Peritoneal Cavity. J Physiol (1897) 0.84
P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg (1999) 0.83
Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol (1994) 0.83